/

LZAGY

Lonza Group AGAfter hours

70.16+2.16 +3.18%USD

OTC Markets OTCPK · as of Oct 14, 15:50 ET · 15m delay

Open

69.51

Prev close

68.00

Day range

69.5170.16

52-week range

58.5374.36

Volume

6.38K0.14×

Mkt cap

49.92B

P/E ttm

36.93

Fwd P/E

26.21

EPS ttm

1.90

Div yield

0.93%

Earnings

—

From 52w high

−5.65%

Price Chart

Yahoo Finance · delayed

LZAGYOct 14, 2026O 69.51H 70.16L 69.51C 70.16+2.11 (+3.10%)Vol 6.38K

SMA 5069.48
SMA 20066.70

1Y change +6.69% since Oct 13, 2025 close540 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

LZAGY Lonza Group AG · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: +1.55%
1 month: +7.28%
3 months: −2.65%
6 months: +2.96%
Year to date: +4.42%
1 year: +6.87%

Valuation & ownership

Market cap: 49.92B
Enterprise value: 51.19B
P/E (ttm): 36.93
Forward P/E: 26.21
PEG ratio: 1.02
Price / book: 5.02
Price / sales (ttm): 7.27
EV / EBITDA: 21.42
EPS (ttm): 1.90
EPS (forward): 2.68
Beta (5y monthly): 0.81
Dividend yield: 0.93%
Payout ratio: 32.54%
Shares outstanding: 698.44M
Float: 697.41M
Short % of float: —
Short ratio (days): —
Held by insiders: 0.00%
Held by institutions: 0.04%
Avg volume (3m): 44.17K
50-day average: 69.46
200-day average: 66.69
52-week change: +6.87%
S&P 500 52-week: +17.00%

Technicals (daily)

RSI (14): 56.2
vs 50-day SMA: +0.97%
vs 200-day SMA: +5.18%
50 / 200-day trend: ▲ 50 above 200
MACD vs signal: ▲ above
ATR (14) % of price: 1.78%
Realised vol (20d, ann.): 22.8%
From 52-week high: −5.65%
From 52-week low: +19.87%

ANR

Analyst Consensus

3 analysts

Consensus

—

Mean target

79.18

+12.85% implied

Low 75.49Median 76.83High 85.20

Recommendation trend

Now2 / 1 / 0
1m ago2 / 1 /

DES

About Lonza Group AG

Yahoo Finance profile

Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.

Sector: Healthcare
Industry: Diagnostics & Research
Employees: 20,141
Headquarters: Basel, Switzerland
Website: lonza.com
Officers: Dr. Wolfgang Wienand Ph.D. Chief Executive Officer
Mr. Philippe Deecke Chief Financial Officer
Mr. Jason Berndt Executive VP & Head of Group Operations

SEAS

Seasonality · LZAGY

2010–2026 · monthly returns

Strongest month Jul +9.17%Weakest month Aug −1.19%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	0.7	2.5	-7.9	-3.8	4.2	5.5	3.1	2.4	-3.7	2.3			+4.4%
2025	7.9	-0.4	-2.4	15.9	-3.1	3.1	-2.3	1.6	-5.9	3.5	-0.6	-2.0	+14.3%
2024	16.3	6.8	14.6	-7.6	-2.0	0.6	22.6	-2.2	-3.4	-2.4	-2.9	-1.8	+39.7%
2023	17.2	4.2	0.6	3.7	1.2	-5.1	-2.9	-4.8	-16.3	-24.4	10.7	9.0	−13.7%
2022	-17.5	0.1	5.2	-18.8	2.4	-11.4	13.1	-11.8	-8.5	5.8	1.7	-6.8	−41.6%
2021	0.1	-1.2	-12.2	13.8	1.5	10.3	9.9	8.3	-11.3	10.2	-2.1	3.5	+30.3%
2020	12.5	-3.0	4.4	4.6	13.6	7.6	17.4	-0.1	-0.6	-2.2	3.7	2.3	+76.2%
2019	1.5	5.0	11.8	-0.1	-0.9	9.9	1.3	3.8	-4.5	6.7	-5.9	7.2	+39.9%
2018	2.2	-7.5	-7.4	3.9	9.4	-1.4	16.1	4.7	5.9	-8.0	3.1	-19.5	−3.7%
2017	1.7	4.4	3.1	8.0	1.5	4.4	10.3	5.8	4.0	1.0	-1.7	3.5	+56.1%
2016	-5.7	-1.6	11.6	-1.2	3.6	-3.5	13.8	-0.4	1.6	-1.3	-5.8	-2.8	+6.5%
2015	5.6	4.0	1.1	14.0	-0.6	-5.1	8.4	-5.3	-4.4	11.9	7.8	2.7	+45.3%
2014	5.8	4.4	-2.5	2.2	3.1	1.1	1.6	3.5	5.4	-8.2	5.7	-4.1	+18.2%
2013	7.4	6.4	4.9	6.9	6.9	1.6	2.1	-8.6	15.5	9.4	4.8	1.5	+74.7%
2012	-9.2	-3.2	-0.6	-13.4	-20.7	16.7	9.0	2.4	13.5	-2.9	-5.9	13.4	−8.0%
2011	-1.5	7.8	-0.8	2.4	0.8	-10.3	9.4	-22.6	-9.7	10.9	-7.6	-3.4	−26.2%
2010		11.3	2.2	-2.7	-15.8	0.8	17.0	6.8	3.0	1.8	-11.5	3.5	+12.6%

CONG

Congress Trades · LZAGY

House and Senate reports since 2025

Members

1 last bought

Buys

~$8.0K

Sells

~$0

Net

+$8.0K

est. bought − sold

Latest

Mar 30, 26

Alan Armstrong

Members who traded it

Member	Buys	Sells	Est. net	Last move
Alan Armstrong Sen. OK	1		+$8.0K	Bought Mar 30, 26

Bought and sold by quarter (est.)

Members of Congress's LZAGY trades, newest first
Traded	Member	Owner	Type	Amount	Filed	Report
Mar 30, 26	Alan Armstrong Sen. OK	Self	Buy	$1,001 - $15,000	Jul 21, 26 (113d)	Report

From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades

LZAGY

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

LZAGY

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Lonza Group AG

Seasonality · LZAGY

Insider Activity · LZAGY

Congress Trades · LZAGY

Members who traded it

Bought and sold by quarter (est.)

Investors Holding LZAGY

Investors Holding LZAGY

Congress Trades · LZAGY

Members who traded it

Bought and sold by quarter (est.)

Seasonality · LZAGY

Insider Activity · LZAGY

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About Lonza Group AG

Financial Snapshot

Earnings & Dividends

News